Evidence map›Paper›PMID 30804885›Full record

ReviewFrontiers in neurology2019

Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple Sclerosis.

Konstantin Huhn, Tobias Engelhorn, Ralf A Linker, Armin M Nagel

Abstract readReview
In one paragraph

Review in Frontiers in neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. A Sub-Microsecond Switch Enabling SWIFTMagnetic resonance in medicine · 2026
    Article
  2. First In VivoMagnetic resonance in medicine · 2026
    Article
  3. Magnetic resonance in medicine · 2026
    Article
  4. Sodium MRI in Pediatric Brain Tumors.AJNR. American journal of neuroradiology · 2025
    Review
  5. Article
  6. Interleaved Whole BrainNMR in biomedicine · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. A uniformity correction method to reduce scan time for 7T sodium imaging of brain tumors.Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2022
    Article
  12. Multinuclear MRI in Drug Discovery.Molecules (Basel, Switzerland) · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. VolumetricZeitschrift fur medizinische Physik · 2022
    Article
  17. Review
  18. Relaxation-weightedTherapeutic advances in chronic disease · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Konstantin HuhnDepartment of Neurology, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.
Tobias EngelhornDepartment of Neuroradiology, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.
Ralf A LinkerDepartment of Neurology, University of Regensburg, Regensburg, Germany.
Armin M NagelDepartment of Radiology, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In multiple sclerosis (MS), experimental and

Indexed as

23Na MRIbiomarkermagnetic resonance imagingmultiple sclerosisneurodegenerationsodium MRI

Identifiers

PMID30804885
PMCPMC6378293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.